PODOCYTES BIOLOGY 1
P1: THE HUMAN GLOMERULAR ENDOTHELIAL GLYCOCALYX: CHARACTERISATION AND BARRIER PROPERTIES
A Singh, University of Bristol

P2: EXOGENOUS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ALTERS MAMMALIAN GLOMERULAR PERMEABILITY VIA AN EFFECT ON GLOMERULAR ENDOTHELIUM
SJ Harper, University of Bristol

P3: HIGH GLUCOSE LEVELS SPECIFICALLY STIMULATE AN INCREASE IN MICROVASCULAR PERMEABILITY IN VIVO
J Harper, Southmead Hospital, Bristol

P4: NEPHRIN IS CRITICAL FOR THE ACTION OF INSULIN ON THE HUMAN GLOMERULAR PODOCYTE
RJM Coward, Southmead Hospital, Bristol

P5: REASSESSMENT OF THE WATER PERMEABILITY OF THE GLOMERULAR FILTRATION BARRIER (GFB)
CR Neal, University of Bristol

HYPERTENSION (BASIC SCIENCE)  
P6: VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF121) ADMINISTRATION FAILS TO IMPROVE RENAL HEALING IN A MODEL OF SALT-SENSITIVE HYPERTENSION INDUCED BY ANGIOTENSIN II
D A Long, University College London

P7: HYPERTENSION AND RENAL SODIUM HANDLING IN THE RAT EXPOSED TO PROTEIN RESTRICTION IN UTERO
SH Al-Wasil, University of Manchester

P8: REGULATION OF ENAC-MEDIATED SODIUM REABSORPTION IN SODIUM-RESTRICTED RATS BY APICAL P2X RECEPTORS: PATCH CLAMP AND MOLECULAR INVESTIGATIONS USING MICRODISSECTED COLLECTING DUCTS
SS Wildman, University College London

P9: RENAL SODIUM HANDLING IN A MOUSE MODEL OF APPARENT MINERALOCORTICOID EXCESS
J.M. Paterson, University of Edinburgh

P10: RENAL EFFECTS OF ACTH EXCESS IN MICE
MA Bailey, University of Edinburgh

CELL SIGNALLING     
P11: BUTYRATE AS A MODULATOR OF TGF-?1 GENERATION AND FUNCTION. POTENTIAL HEALTH BENEFIT FOR ACACIA(SEN) SUPER GUM(r)(GUM ARABIC)?
SG Riley, University Hospital of Wales

P12: PHOSPHORYLATION REGULATES A POLYCYSTIN-2 LIKE CONDUCTANCE IN AN IMMORTAL MOUSE COLLECTING DUCT CELL LINE
AT Lee, University of Sheffield

P13: THE REGULATION OF ERIC-1, AN ERYTHROPOIETIN INDUCED GENE.
N.A. Morgan, Belfast City Hospital

P14: INTERLEUKIN-1 SENSITISES PROXIMAL TUBULAR EPITHELIAL CELLS TO TGF BETA VIA A CD44 DEPENDENT MECHANISM
D J Fraser, University Hospital of Wales

P15: EXTRACELLULAR SIGNAL RELATED KINASE (ERK) ACTIVITY IS REQUIRED FOR GROWTH OF MDCK-DERIVED CYSTS
C.M. Turner, Royal Free and University College of London Medical School

TUBULAR BIOLOGY 1      
P16: CALPAIN 2 MEDIATES AN EARLY, HIGH GLUCOSE-INDUCED PARP-INDEPENDENT NECROSIS IN PROXIMAL TUBULAR EPITHELIAL CELLS
SM Harwood, William Harvey Research Institute, London

P17: FURTHER INVESTIGATION INTO THE REGULATION OF ERK5 ACTIVITY IN HUMAN PROXIMAL TUBULE EPITHELIAL CELLS
J A Browne, St Helier Hospital, Carshalton

P18: PROPERTIES OF BA2+ BLOCK OF AN INWARDLY RECTIFYING K+ CONDUCTANCE IN CULTURED MOUSE COLLECTING DUCT CELLS.
H Taylor, University of Sheffield

P19: GLUT2 TRANSPORTER EXPRESSION AT THE PROXIMAL TUBULE BRUSH BORDER MEMBRANE CORRELATES WITH PLASMA GLUCOSE CONCENTRATION
J Marks, Royal Free & University College Medical School, London

P20: BMP-7 ACTIVATION OF PROXIMAL TUBULAR CELLS: A FOCUS ON RELATIONSHIP BETWEEN P38 (MAPK) AND SMAD SIGNALLING
R Motazed, St Helier Hospital, Carshalton

P21: ROLE PLAYED BY DISABLED2 (DAB2) IN ALBUMIN INDUCED MAPKINASE SIGNALLING PATHWAY IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS (PTECS)
R Diwakar, St Helier Hospital, Carshalton

P22: IDENTIFICATION OF A PUTATIVE FOCAL POINT OF BMP7-TGF?1 INTERACTION IN HUMAN PROXIMAL TUBULE EPITHELIAL CELLS
M.K Phanish, St.Helier Hospital, Carshalton

P23: FUNCTIONAL ROLE OF THE N-TERMINUS OF THE MOUSE UREA TRANSPORTER MUT-A3
VM Collins, University of Sheffield

TRANSPLANT (CLINICAL) 1    
P24: TRANSPLANT RENAL ARTERY STENOSIS: 5 YEAR RESULTS OF TREATMENT BY ANGIOPLASTY AND STENTING
K Chan, Hammersmith Hospital, London

P25: CAMPATH AND MEDIUM DOSE TACROLIMUS MONOTHERAPY IN RENAL TRANSPLANTATION: INCIDENCE OF SIGNIFICANT INFECTIONS
K Chan, Hammersmith Hospital, London

P26: BODY MASS INDEX IS ASSOCIATED WITH PROGRESSION OF PROTEINURIA IN RENAL TRANSPLANT RECIPIENTS
K Armstrong, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia

P27: AN ORAL GLUCOSE TOLERANCE TEST SHOULD BE PERFORMED ROUTINELY IN ALL ESTABLISHED RENAL TRANSPLANT RECIPIENT
KA Armstrong, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia

P28: ASSESSMENT OF THE CARE PATHWAY FOR THE PATIENT WITH THE FAILING TRANSPLANT
J Popoola, St George's Hospital, London

P29: EFFECT OF EARLY CMV INFECTION OR DISEASE ON RENAL FUNCTION POST RENAL TRANSPLANT IN THE ABSENCE OF ACUTE REJECTION
K. McCafferty, Barts and the London NHS Trust, London

P30: MMF DISCONTINUATION LEADS TO INFERIOR GRAFT FUNCTION AND SURVIVAL
S Shah, University of London

P31: THERAPEUTIC STRATEGY WITH A MEMBRANE-LOCALIZING COMPLEMENT REGULATOR TO INCREASE THE NUMBER OF USABLE DONOR ORGANS AFTER PROLONGED COLD STORAGE
W Zhou, Guy's Hospital, London

P32: THE INFLUENCE OF DONOR C3 ALLOTYPE ON LATE RENAL TRANSPLANT OUTCOME
KM Brown, Guy's Hospital, London

CHRONIC KIDNEY DISEASE 1
P33: VITAMIN D INSUFFICIENCY IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) STAGES 3 AND 4 CORRELATES WITH DEGREE OF PROTEINURIA
AS Stavroulopoulos, Nottingham City Hospital

P34: PREVALENCE OF CHRONIC KIDNEY DISEASE (CKD) STAGES 3 AND 4 IN PATIENTS WITH LIMB FRAGILITY FRACTURES
AS Stavroulopoulos, Nottingham City Hospital

P35: THE COST IMPLICATIONS OF THE NEW UK GUIDELINES FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE
B Klebe, Kent and Canterbury Hospital

P36: KEAPS STUDY: DOES ALBUMINURIA RUN IN FAMILIES?
AK Bello, University of Sheffield

P37: LATE PRESENTATION TO RENAL REPLACEMENT THERAPY-CAN WE MAKE A DIFFERENCE?
NA Thomas, University Hospital of Wales

P38: PROGNOSTIC VALUE OF CARDIAC BIOMARKERS IN A CKD POPULATION
MC Webb, Kent and Canterbury Hospital

P39: SIGNIFICANT ATHEROSCLEROTIC RENOVASCULAR DISEASE IS ASSOCIATED WITH HIGHER IGFBP-1 LEVELS
CM Cheung, Hope Hospital, Salford

P40: THE BENEFICIAL EFFECTS OF RESISTANCE TRAINING ON FUNCTIONAL CAPACITY, REGIONAL BODY COMPOSITION AND SELF-REPORTED URAEMIC SYMPTOMS IN CKD3 PATIENTS
J Kinsella, University Hospital North Staffs

P41: THE CONTENT OF GENERAL PRACTITIONER REFERRAL LETTERS TO OUTPATIENT NEPHROLOGY SERVICES
RJ Sims, United Lincolnshire Hospital

P42: DIFFERENTIAL EFFECTS OF STATINS ON CALCIUM DEPOSITION IN SUB-POPULATIONS OF BOVINE AORTIC SMOOTH MUSCLE CELL: POSSIBLE MODULATION BY EFFECTS ON GROWTH FACTOR SIGNALLING
KW Siddals, Hope Hosptial, Salford

CARDIOVASCULAR RISK 1     
P43: DIFFERENTIAL EFFECTS OF NITROGENOUS AND NON-NITROGENOUS BISPHOSPHONATES ON THE DIFFERENTIATION AND CALCIUM DEPOSITION OF BOVINE AORTIC SMOOTH MUSCLE CELLS
KW Siddals, Hope Hosptial, Salford

P44: EFFECT OF OXIDATIVE STRESS AND VASCULAR ABNORMALITIES ON SURVIVAL OF HAEMODIALYSIS (HD) PATIENTS
BA Ahmed, Northern General Hospital, Sheffield

P45: GLOBAL RISK ASSESSMENT OF CORONARY HEART DISEASE IN STAGE 5 CKD PATIENTS BY DIFFERENT SCORING SYSTEMS.
NY Abosaif, St Helier Hospital, Carshalton

P46: THE CLUSTERING OF ATHEROSCLEROTIC AND INFLAMMATORY CARDIOVASCULAR RISK FACTORS IN CHRONIC KIDNEY DISEASE PATIENTS
RK Wan, University of Glasgow

P47: INTRODUCTION OF A PROFORMA-BASED SERVICE SIGNIFICANTLY IMPROVES THE MANAGEMENT OF CARDIOVASCULAR RISK FACTORS IN A RENAL TRANSPLANT POPULATION
D Kavanagh, Washington University School of Medicine, USA

HAEMODIALYSIS 1
P48: THE EFFECT OF A SINGLE MAINTENANCE HAEMODIALYSIS SESSION ON PERFORMANCE BASED ASSESSMENTS OF FALLS RISK IN OLDER ADULTS
RJA Sims, Nottingham City Hospital

P49: DIALYSIS-INDUCED MYOCARDIAL STUNNING: A POTENTIAL MECHANISM FOR HEART FAILURE?
NM Selby, Derby City Hospital

P50: DIFFERENTIAL CARDIOVASCULAR RESPONSE TO DOBUTAMINE STRESS IN INTRADIALYTIC HYPOTENSION (IDH) PRONE HAEMODIALYSIS PATIENTS
WS Priestman, Derby City General Hospital

P51: UNINTENTIONAL SYSTEMIC ANTICOAGULATION DUE TO LINELOCKS
R Pepper, Hammersmith Hospital, London

P52: DEUTERIUM KINETICS IN HAEMODIALYSIS PATIENTS AND THE OPTIMAL TIME SCHEDULE FOR BREATH SAMPLING IN DETERMINATION OF TOTAL BODY WATER (TBW) USING FLOWING AFTERGLOW MASS SPECTROMETRY (FAMS)
C Chan, University Hospital of North Staffordshire

P53: THE RELATIONSHIP BETWEEN SLEEP, ITCH, PAIN AND DEPRESSION IN HAEMODIALYSIS PATIENTS
S Lines, York Hospital

P54: FOOD INTAKE DURING HAEMODIALYSIS REDUCES RELATIVE BLOOD VOLUME
M Sivalingam, Lister Hospital, Stevenage

P55: BLOOD PRESSURE CONTROL IN CHRONIC HAEMODIALYSIS PATIENTS
R C Thuraisingham, Royal London Hospital

P56: SURVIVAL IN DIALYSIS DEPENDENT END-STAGE RENAL FAILURE: A PROSPECTIVE COHORT STUDY
P Jain, Queen Elizabeth Hospital, Birmingham

P57: PRESENTATION AND TREATMENT OF TUBERCULOSIS IN SOUTH ASIANS ON RENAL REPLACEMENT THERAPY
S Goel, Hammersmith Hospital, London

P58: SEX, SIZE, KT/V AND INADVERTENT UNDERDIALYSIS
S M Chandna, Lister Hospital, Stevenage

P59: FREE LIGHT CHAIN REMOVAL FROM SERUM BY HAEMOFILTRATION: A COMPARISON OF DIALYSIS MEMBRANES IN VITRO
SD Reid, The Binding Site Ltd, Birmingham

CHRONIC KIDNEY DISEASE 2    
P60: MGUS INCIDENCE IN A CHRONIC KIDNEY DISEASE POPULATION
SD Reid, The Binding Site Ltd, Birmingham

P61: PREVALENCE OF CHRONIC KIDNEY DISEASE AND RENAL ANAEMIA IN ACUTE MEDICAL ADMISSIONS
NMP Annear, St Georges Hospital, London

P62: CHRONIC KIDNEY DISEASE: THE QUALITATIVE EXPERIENCES OF INDIVIDUALS IN THE COMMUNITY SETTING
J.C. Bridger, University of the West of England, Bristol

P63: SJÖGREN'S SYNDROME AS A CAUSE OF END-STAGE RENAL FAILURE IN CHILDHOOD
SA Johnson, Birmingham Children's Hospital

P64: A LARGE CROSS SECTIONAL SURVEY OF PAIN EXPERIENCED IN SUBJECTS WITH RENAL DISEASES
K Mccarthy, University Hospitals Coventry and Warwickshire

P65: A RETRORESPECTIVE CASE SERIES OF RETROPERITONEAL FIBROSIS TREATED WITH STEROIDS
S Kallankara, Hull & East Yorkshire Hospitals NHS Trust

NUTRITION 1   
P66: EVALUATING A NUTRITION REFERRAL TOOL APPROPRIATE FOR RENAL INPATIENTS
SM Underwood, Kent and Canterbury Hospital

P67: THE MOST SEVERE CASES OF HAEMODIALYSIS-RELATED CACHEXIA ARE PREDICTED BY WEIGHT LOSS TRENDS 12 MONTHS EARLIER.
P Choi, Hammersmith Hospital, London

P68: SOCIAL CIRCUMSTANCES PREDICT HAEMODIALYSIS-RELATED CACHEXIA AS WELL AS PATIENT DEMOGRAPHICS AND CO-MORBIDITY
P Choi, Hammersmith Hospital, London

P69: HANDGRIP DYNAMETER SHOWS AN ASSOCIATION WITH APPENDICULAR LEAN MASS AND BODY CELL MASS IN PATIENTS AS THEY COMMENCE DIALYSIS THERAPY
H Campbell, Leeds General Infirmary

P70: IS SERUM TRANSFERRIN SUPERIOR TO ALBUMIN AS A NUTRITIONAL MARKER IN ESRF?
L Wells, York Hospital

P71: PRE-DIALYSIS - THE MOUNTAIN WE HAVE TO CLIMB?
JK Curwell, Manchester Royal Infirmary

P72: IMPACT ON PHOSPHATE LEVELS OF IMAGES SHOWN TO PATIENTS WITH LONGSTANDING HYPERPHOSPHATAEMIA
JC McFadyen, Hull Royal Infirmary

P73: A DIETITIAN-LED EDUCATION PROGRAMME TO IMPROVE PHOSPHATE CONTROL IN A SINGLE CENTRE HAEMODIALYSIS POPULATION
N Sethi, St Luke's Hospital, Bradford

PALLIATIVE CARE
P74: A CARE PATHWAY FOR THE END OF LIFE IN A RENAL SETTING
VC Hinton, Nottingham City Hospital

P75: THE INCEPTION OF A CONSERVATIVE CARE PROGRAMME.
JR Webster, Royal Infirmary of Edinburgh

P76: ANALGESIC PRESCRIBING PRACTICES IN PALLIATIVE CARE PATIENTS WITH RENAL FAILURE: A RETROSPECTIVE STUDY AND DEVELOPMENT OF EVIDENCE BASED GUIDELINES
C A Douglas, Marie Curie Palliative Care Institute, Liverpool

P77: PROVISION OF SPECIALIST PALLIATIVE CARE TO PATIENTS WITH END-STAGE RENAL DISEASE
C Byrne, Hope Hospital, Salford

P78: WHICH PATIENTS CHOSE NOT TO DIALYSE?
J Baharani, Birmingham Heartlands Hospital